LOW-VOLUME · HOSP-HEAVY
nisoldipine Side Effects
nisoldipine (also sold as Sular) is a LOW-VOLUME FAERS extract #484 of 524 by FAERS report count. Still opens on HOSP-HEAVY: 33.1% mention hospitalization (394 reports).
Data updated 2026-05-15
- 1,191
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
nisoldipine: 33.1% mention hospitalization (394 reports). Death stamp DEATH-HEAVY; volume band LOW-VOLUME #484 of 524 by FAERS report count.
Thinner FAERS extract for nisoldipine (Sular) (1,191 reports #484 of 524 by FAERS report count). 33.1% mention hospitalization (394 reports). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2004–2025). Stamps SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
NAUSEA leads 88 of 1,191 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (264 reports)
Reporting taper since 2004 peak
Reactions in Death Reports
Death-mentioned subset is HEAVY here (123 reports, 10.3%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 39 |
| RENAL FAILURE | 21 |
| MYOCARDIAL INFARCTION | 19 |
| COMPLETED SUICIDE | 17 |
| INJURY | 14 |
| ASTHENIA | 13 |
| CARDIAC FAILURE CONGESTIVE | 12 |
| PAIN | 12 |
| PNEUMONIA | 12 |
| ANXIETY | 11 |
| DYSPNOEA | 10 |
| RESPIRATORY FAILURE | 9 |
| CHRONIC KIDNEY DISEASE | 8 |
| DIARRHOEA | 8 |
| NAUSEA | 8 |
| WEIGHT DECREASED | 8 |
| ANHEDONIA | 7 |
| ATRIAL FIBRILLATION | 7 |
| DIZZINESS | 7 |
| END STAGE RENAL DISEASE | 7 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (394, 33.1% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| DYSPNOEA | 43 |
| MYOCARDIAL INFARCTION | 39 |
| CARDIAC FAILURE CONGESTIVE | 35 |
| RENAL FAILURE | 35 |
| ASTHENIA | 34 |
| NAUSEA | 33 |
| PAIN | 33 |
| ANXIETY | 31 |
| CEREBROVASCULAR ACCIDENT | 31 |
| PNEUMONIA | 31 |
| DIARRHOEA | 29 |
| DIZZINESS | 27 |
| FATIGUE | 26 |
| CORONARY ARTERY DISEASE | 25 |
| HEADACHE | 24 |
| HYPERTENSION | 24 |
| BACK PAIN | 23 |
| CHEST PAIN | 23 |
| ATRIAL FIBRILLATION | 22 |
| INJURY | 22 |
How to read nisoldipine FAERS figures (SIGNAL · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 1,191 voluntary reports linked to nisoldipine (Sular), 2004-2025. Death is listed on 123 (10.3%). Hospitalization appears on 394 (33.1%). Top co-reported indication: Hypertension.
Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.
Read with nisoldipine
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 1,205 FAERS cases (Δ 14 heavier vs nisoldipine); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 1,220 FAERS cases (Δ 29 heavier vs nisoldipine); DEATH-MARKED · HOSP-HEAVY · FEMALE-LED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 1,152 FAERS cases (Δ 39 lighter vs nisoldipine); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 1,132 FAERS cases (Δ 59 lighter vs nisoldipine); DEATH-MARKED · HOSP-MID · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 51.8 pp vs nisoldipine's DEATH-HEAVY): CASELOAD · HOSP-MID.
nisoldipine stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload SIGNAL and the label guide.